Pivotal Phase 3 Data Presented at ISTH 2023 Congress Spotlight TAK-755 Prophylaxis for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2023--
Stay updated with breaking news from Daniel Curran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2023--
£600 million of unclaimed estates currently in London
The FDA has accepted for Priority Review the BLA for TAK-755 for the treatment of congenital thrombotic thrombocytopenic purpura.
05.01.2023 - Takeda (TSE:4502/NYSE:TAK) today announced that the totality of evidence from a pre-planned interim analysis of a pivotal Phase 3 study supports the efficacy and safety of TAK-755 as enzyme replacement therapy for congenital thrombotic ... Seite 1
Ex-priest Daniel Curran breached a Sexual Offences Prevention Order by visiting an activity centre.